cycloheximide has been researched along with ergoline in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gorski, J; Shull, JD | 1 |
Boulton, AA; Juorio, AV; Paterson, IA; Zhu, MY | 1 |
Matsubara, K; Ohtaki, K; Shimizu, K; Shiono, H | 1 |
3 other study(ies) available for cycloheximide and ergoline
Article | Year |
---|---|
Regulation of prolactin gene transcription in vivo: interactions between estrogen, pimozide, and alpha-ergocryptine.
Topics: Animals; Cell Nucleus; Cycloheximide; Dopamine Agents; Dopamine Antagonists; Drug Interactions; Ergolines; Estradiol; Estrogens; Gene Expression Regulation; Isomerism; Male; Pimozide; Pituitary Gland, Anterior; Prolactin; Rats; Transcription, Genetic | 1990 |
Regulation of striatal aromatic L-amino acid decarboxylase: effects of blockade or activation of dopamine receptors.
Topics: Animals; Antipsychotic Agents; Aromatic-L-Amino-Acid Decarboxylases; Benzazepines; Bromocriptine; Corpus Striatum; Cycloheximide; Dextroamphetamine; Dopamine D2 Receptor Antagonists; Drug Interactions; Ergolines; Flupenthixol; Male; Pimozide; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Remoxipride; Stereoisomerism | 1993 |
Paraquat leads to dopaminergic neural vulnerability in organotypic midbrain culture.
Topics: 1-Methyl-4-phenylpyridinium; Analysis of Variance; Animals; Animals, Newborn; Azepines; Cabergoline; Caspases; Cell Count; Cycloheximide; Dizocilpine Maleate; Dopamine Agonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Enzyme Inhibitors; Ergolines; Excitatory Amino Acid Antagonists; Herbicides; Immunohistochemistry; Mesencephalon; NADPH Dehydrogenase; Neuroprotective Agents; NG-Nitroarginine Methyl Ester; Organ Culture Techniques; Paraquat; Piperazines; Protein Synthesis Inhibitors; Quinoxalines; Rats; Rats, Wistar; Selegiline; Tyrosine 3-Monooxygenase | 2003 |